Skip to content

Clinical study of ultrasound-guided trigger point dry needling combined with high-intensity laser therapy for neck type cervical spondylopathy:A randomized controlled study

Clinical study of ultrasound-guided trigger point dry needling combined with high-intensity laser therapy for neck type cervical spondylopathy:A randomized controlled study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500099825
Enrollment
Unknown
Registered
2025-03-31
Start date
2025-04-01
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

neck type cervical spondylopathy

Interventions

Dry Needling Combined with High-Energy Laser Therapy Group:Ultrasound-guided dry needling followed by high-energy laser therapy after 30 minutes
two in-hospital treatment sessions at 5-day intervals.
Dry Needling Combined with Sham Laser Therapy Group:Ultrasound-guided dry needling followed by sham laser therapy after 30 minutes

Sponsors

Affiliated Hospital of Xuzhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Meeting the diagnostic criteria for neck-type cervical spondylosis as published in the 2018 Chinese Journal of Surgery; 2. Aged between 18 and 70 years, with a body mass index (BMI) ranging from 18.5 to 28 kg/m^2; 3. Disease duration of at least 3 months; 4. Numeric Rating Scale (NRS) score >= 4; 5. Inadequate therapeutic response to oral medication alone; 6. Willingness to participate in the study and provision of signed informed consent.

Exclusion criteria

Exclusion criteria: 1. Patients with a history of neck trauma, cervical spine surgery, cervical myelopathy, or other organic cervical pathologies; 2. Poorly controlled diabetes mellitus or hypertension; 3. Severe hematologic disorders or coagulation abnormalities; 4. Local skin lesions, infections, or dermatologic conditions (e.g., rashes) in the treatment area; 5. Cognitive impairment, psychiatric disorders, or other conditions that may interfere with clinical evaluation; 6. Needle phobia, allergy to medications used in this study, or contraindications to high-energy laser therapy.

Design outcomes

Primary

MeasureTime frame
Numeric Rating Scale;

Secondary

MeasureTime frame
Short-Form McGill Pain Questionnaire-2;Neck Disability Index;Cervical?Range?of?Motion;Athens Insomnia Scale;Hospital Anxiety and Depression Scale;Heart Rate Variability;Patient satisfaction;

Countries

China

Contacts

Public ContactYan Yuan

Affiliated Hospital of Xuzhou Medical University

1046817112@qq.com+86 180 5226 8635

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026